Αποτελέσματα Αναζήτησης
16 Απρ 2020 · The purpose of these guidelines is to provide evidence-based recommendations to facilitate prevention, diagnosis, and treatment of neurological morbidity, including strokes, silent cerebral infarcts, and cognitive morbidity, in children and adults with SCD.
19 Ιουν 2020 · In general, the optimal treatment of both acute and chronic pain requires an individualized approach that involves interdisciplinary care. This approach encompasses pharmacological, nonpharmacological, and integrative therapeutic interventions that are tailored to individual patient needs.
3 Δεκ 2019 · The American Society of Hematology (ASH) convened 5 guideline panels to develop clinical practice recommendations addressing 5 management areas of highest importance to individuals living with sickle cell disease: pain, cerebrovascular complications, pulmonary and kidney complications, transfusion, and hematopoietic stem cell transplant.
• Evidence-based treatment guidelines for sickle cell disease complications that affect the heart, lungs, and kidneys. • SCD affects multiple organs that require patients to seek care from doctors that
ASH appointed 61 clinical experts, five methodologists and 10 patient representatives to review evidence and form recommendations on SCD. The recommendations address treatment of both adult and pediatric SCD. The systematic review of evidence was led by the Mayo Clinic Evidence-Based Practice Center.
These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD.
25 Φεβ 2024 · Implement evidence-based treatment and management options available for sickle cell crisis. Develop interprofessional team strategies for improving care coordination to manage sickle cell crises and improve outcomes. Access free multiple choice questions on this topic.
